108 related articles for article (PubMed ID: 30543932)
21. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
Heo JH; Song JY; Jeong JY; Kim G; Kim TH; Kang H; Kwon AY; An HJ
J Clin Pathol; 2016 Feb; 69(2):109-16. PubMed ID: 26251522
[TBL] [Abstract][Full Text] [Related]
22. Label-free LC-MSe in tissue and serum reveals protein networks underlying differences between benign and malignant serous ovarian tumors.
Wegdam W; Argmann CA; Kramer G; Vissers JP; Buist MR; Kenter GG; Aerts JM; Meijer D; Moerland PD
PLoS One; 2014; 9(9):e108046. PubMed ID: 25265318
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1.
Liang T; Guo Q; Li L; Cheng Y; Ren C; Zhang G
Neoplasma; 2016; 63(5):696-704. PubMed ID: 27468873
[TBL] [Abstract][Full Text] [Related]
24. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
25. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.
Collins Y; Tan DF; Pejovic T; Mor G; Qian F; Rutherford T; Varma R; McQuaid D; Driscoll D; Jiang M; Deeb G; Lele S; Nowak N; Odunsi K
Int J Mol Med; 2004 Jul; 14(1):43-53. PubMed ID: 15202015
[TBL] [Abstract][Full Text] [Related]
26. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.
Arts FA; Keogh L; Smyth P; O'Toole S; Ta R; Gleeson N; O'Leary JJ; Flavin R; Sheils O
Hum Pathol; 2017 Dec; 70():98-104. PubMed ID: 29079174
[TBL] [Abstract][Full Text] [Related]
27. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
Greening DW; Kapp EA; Simpson RJ
Enzymes; 2017; 42():27-64. PubMed ID: 29054270
[TBL] [Abstract][Full Text] [Related]
28. Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX
Wang X; Liu G; Sheng N; Zhang M; Pan X; Liu S; Huang K; Cong Y; Xu Q; Jia X; Xu J
Ann Transl Med; 2020 Aug; 8(15):925. PubMed ID: 32953725
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of autophagy gene Beclin1 to tumorigenesis and development of epithelial ovarian cancer].
Duan ZL; Peng ZL; Wang ZH; Yan NH
Ai Zheng; 2007 Mar; 26(3):258-63. PubMed ID: 17355787
[TBL] [Abstract][Full Text] [Related]
30. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
[TBL] [Abstract][Full Text] [Related]
31. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
32. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
33. CTD-2020K17.1, a Novel Long Non-Coding RNA, Promotes Migration, Invasion, and Proliferation of Serous Ovarian Cancer Cells In Vitro.
Zhu L; Guo Q; Lu X; Zhao J; Shi J; Wang Z; Zhou X
Med Sci Monit; 2018 Mar; 24():1329-1339. PubMed ID: 29504606
[TBL] [Abstract][Full Text] [Related]
34. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells.
He LC; Gao FH; Xu HZ; Zhao S; Ma CM; Li J; Zhang S; Wu YL
Oncol Rep; 2012 Oct; 28(4):1399-405. PubMed ID: 22859015
[TBL] [Abstract][Full Text] [Related]
35. Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro.
Zhu YF; Gao GL; Tang SB; Zhang ZD; Huang QS
Asian Pac J Trop Med; 2013 Apr; 6(4):265-72. PubMed ID: 23608327
[TBL] [Abstract][Full Text] [Related]
36. In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.
Nepomuceno AI; Shao H; Jing K; Ma Y; Petitte JN; Idowu MO; Muddiman DC; Fang X; Hawkridge AM
Anal Bioanal Chem; 2015 Sep; 407(22):6851-63. PubMed ID: 26159569
[TBL] [Abstract][Full Text] [Related]
37. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Zorn KK; Jazaeri AA; Awtrey CS; Gardner GJ; Mok SC; Boyd J; Birrer MJ
Clin Cancer Res; 2003 Oct; 9(13):4811-8. PubMed ID: 14581352
[TBL] [Abstract][Full Text] [Related]
38. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
39. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
[TBL] [Abstract][Full Text] [Related]
40. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
